EW
NYSEEdwards Lifesciences Corp
Health Care, Health Care Equipment
$89.72
close 7 Aug 2026
+14.79%
52-week change
$51.73B
market cap
$72.30
$96.29
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||||||||||||
| Revenue | $6.51B | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B | $4.39B | $4.35B | $3.72B | $3.44B | $2.96B | $2.49B | $2.32B | $2.05B | $1.90B | $1.68B | $1.45B | $1.32B | $1.24B |
| Cost of revenue | $1.44B | $1.33B | $1.12B | $978.40M | $723.70M | $1.25B | $1.08B | $1.11B | $939.40M | $875.30M | $797.40M | $617.20M | $625.60M | $516.60M | $491.00M | $489.80M | $408.30M | $399.10M | $419.60M |
| Gross profit | $5.07B | $4.73B | $4.32B | $4.03B | $3.74B | $3.98B | $3.31B | $3.23B | $2.78B | $2.56B | $2.17B | $1.88B | $1.70B | $1.53B | $1.41B | $1.19B | $1.04B | $922.30M | $818.10M |
| R&D | $1.09B | $1.08B | $1.05B | $962.90M | $843.60M | $903.10M | $760.70M | $752.70M | $622.20M | $552.60M | $442.20M | $382.90M | $346.50M | $323.00M | $291.30M | $246.30M | $204.40M | $175.50M | $139.20M |
| SG&A | $2.20B | $2.09B | $1.79B | $1.58B | $1.36B | $1.49B | $1.23B | $1.24B | $1.09B | $990.80M | $904.70M | $850.70M | $858.00M | $733.40M | $697.40M | $642.40M | $550.00M | $508.80M | $480.60M |
| Operating income | $1.45B | $1.26B | $1.38B | $1.31B | $1.50B | $1.69B | $897.60M | $1.15B | $748.20M | $1.09B | $751.20M | — | — | — | — | — | — | — | — |
| Interest expense | $20.40M | $20.40M | $19.80M | $17.60M | $19.20M | $18.40M | $15.80M | $20.70M | $29.90M | $23.20M | $19.20M | $17.20M | $17.20M | $9.80M | $4.40M | $3.10M | $2.40M | $2.70M | $7.20M |
| Tax expense | $439.00M | $216.90M | $152.10M | $152.40M | $195.50M | $198.90M | $93.30M | $119.60M | $39.20M | $451.30M | $168.40M | $127.50M | $332.90M | $122.10M | $96.70M | $46.90M | $50.20M | $75.30M | $35.50M |
| Net income | $1.01B | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B | $823.40M | $1.05B | $722.20M | $583.60M | $569.50M | $494.90M | $811.10M | $389.10M | $291.50M | $236.70M | $218.00M | $229.10M | $128.90M |
| Diluted EPS | $1.74 | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 | $1.30 | $1.64 | $1.13 | $2.70 | $2.61 | $2.25 | $3.74 | $1.71 | $2.46 | $1.98 | $1.83 | $1.95 | $1.10 |
| Gross margin | 77.84% | 78.01% | 79.46% | 80.47% | 83.79% | 76.13% | 75.36% | 74.37% | 74.77% | 74.52% | 73.09% | 75.25% | 73.07% | 74.74% | 74.15% | 70.82% | 71.78% | 69.80% | 66.10% |
| Operating margin | 22.25% | 20.84% | 25.35% | 26.13% | 33.57% | 32.30% | 20.46% | 26.38% | 20.10% | 31.71% | 25.35% | — | — | — | — | — | — | — | — |
| Net margin | 15.46% | 17.69% | 76.75% | 27.99% | 34.09% | 28.73% | 18.77% | 24.08% | 19.40% | 16.99% | 19.22% | 19.85% | 34.92% | 19.02% | 15.35% | 14.10% | 15.07% | 17.34% | 10.41% |
filed 4 Aug 2026